Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria
Conditions: COVID-19 Interventions: Biological: Vaccination against SARS-CoV-2 Sponsors: Medical University of Graz; AGES; Medical University Innsbruck; Austrian Science Fund (FWF) Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Austria Health | Coronavirus | Covid Vaccine | COVID-19 | Research | Respiratory Medicine | SARS | Science | Vaccines